Trial intelligence / Profile preview

Formoterol Fumarate and Mometasone Furoate vs Mometasone Furoate in Persistent Asthma

CTR20140781Phase 4Completed

Sponsor
Merck & Co.
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mometasone furoate + formoterol fumarate in asthma, sponsored by Merck & Co.. Started Mar 2015; status: completed.

02

Drugs

mometasone furoate + formoterol fumarate
03

Conditions

asthma

Beyond the preview

Go deeper on CTR20140781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call